This week on "The Readout LOUD" podcast: an AI experiment at the FDA and how Novo Nordisk is trailing in the obesity drug ...

The former workers cited various reasons why they think Novo was cautious: its conservative culture and history of investing ...

Human insulin presents Indian companies an opportunity estimated at Rs 450 crore per annum in India and $157 million/annum in ...

DEPARTMENT OF JUSTICE NEWS RELEASE Attorney General Raúl Torrez announced settlements with two major insulin ...

Jefferies has predicted more small tuck-in deals to come, as biotechs struggle to access capital despite key clinical ...

The attorney general described the agreements as "huge wins" for New Mexico, which is home to more than 200,000 adults with ...

This article summarizes recent developments in the health sector, including major acquisitions, drug trial results, and ...

Novo Nordisk accounts for 34% of the global diabetes ... qualities that it shares with the only two other global insulin players, Sanofi and Eli Lilly. However, we don't think Novo's cost ...